Literature DB >> 32338707

Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient.

Samir Sulemane1, Aigul Baltabaeva1, Anthony J Barron1, Ruth Chester1, Shelley Rahman-Haley1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32338707      PMCID: PMC7197611          DOI: 10.1093/ehjci/jeaa115

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


× No keyword cloud information.
We were presented with a 60-year-old SARS-CoV-2- (Covid-19) positive gentleman who was transferred to our intensive care unit from a district general hospital. The patient was intubated and required mechanical ventilation prior to transfer for type 1 respiratory failure secondary to pneumonitis. His past medical history included hypertension and hypercholesterolaemia. Admission blood tests demonstrated markedly elevated troponin I of 593 ng/L and C-reactive protein of 360 mg/L. D-dimer levels were elevated at 32 228 ng/L. Bedside echocardiogram showed a dilated right ventricle (base 45 mm, mid 42 mm) with severely impaired right ventricular (RV) systolic function. Basal–mid RV free wall segments were akinetic, while apical segments were normokinetic (Panel A;Supplementary material online Video S1), suggestive of McConnell’s sign. Estimated pulmonary artery systolic pressure was 33 mmHg + right atrial pressures (Panel B1), and pulmonic valve acceleration time was 60 ms (Panel B2) indicative of the 60/60 sign. Combined, both signs are a sensitive marker for acute pulmonary embolism. Additionally, echo imaging showed a small, highly mobile mural thrombus within the RV free wall (Panel C;Supplementary material online Video S2). Subsequent CT pulmonary angiogram confirmed multiple filling defects in the inferior lingula (Panel D1) and in the segmental pulmonary artery branches to the lateral segment of the right middle lobe (Panel D2). The patient was thrombolysed and remains in intensive care. Incoming data from China and Europe suggest that COVID-19 may be associated with a hypercoagulable state and increased risk for venous thrombo-embolism. An association between COVID-19 pneumonia and pulmonary emboli can be challenging for intensive care clinicians given the overlap in symptoms between both. We found bedside echocardiography (McConnell’s and 60/60 sign) to be sensitive in early detection of acute pulmonary embolism, which can aid management in COVID-19-positive patients. (Panel A) Apical 4-chamber view. Akinetic right ventricular basal–mid free wall (yellow arrow) and normokinetic apical segments (red arrows) indicative of McConnell’s sign. We suggest watching Supplementary material online Video S1. (Panel B) The 60/60 sign is present when the pulmonary valve acceleration time is ≤60 ms and the tricuspid regurgitation pressure gradient is ≤60 mmHg. (Panel C) Small, highly mobile, right ventricular thrombus: red arrows. We suggest watching Supplementary material online Video S2. (Panel D) CT pulmonary angiogram showing bilateral pulmonary emboli: white arrows. Supplementary data are available at European Heart Journal - Cardiovascular Imaging online. Click here for additional data file.
  8 in total

1.  Right Heart Thrombus in an Adult COVID-19 Patient: A Case Report.

Authors:  Enrico Merlo; Giuseppe Grutta; Ivo Tiberio; Gabriele Martelli
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-11-07

2.  Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis.

Authors:  Fernando Scudiero; Antonino Pitì; Roberto Keim; Guido Parodi
Journal:  Eur Heart J Case Rep       Date:  2020-12-28

3.  [Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak].

Authors:  Jorge Solano-López; José Luis Zamorano; Ana Pardo Sanz; Ignacio Amat-Santos; Fernando Sarnago; Enrique Gutiérrez Ibañes; Juan Sanchis; Juan Ramón Rey Blas; Joan Antoni Gómez-Hospital; Sandra Santos Martínez; Nicolás Manuel Maneiro-Melón; Roberto Mateos Gaitán; Jessika González D'Gregorio; Luisa Salido; José L Mestre; Marcelo Sanmartín; Ángel Sánchez-Recalde
Journal:  Rev Esp Cardiol       Date:  2020-09-17       Impact factor: 4.753

4.  Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

Review 5.  Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review.

Authors:  Yasser Sakr; Manuela Giovini; Marc Leone; Giacinto Pizzilli; Andreas Kortgen; Michael Bauer; Tommaso Tonetti; Gary Duclos; Laurent Zieleskiewicz; Samuel Buschbeck; V Marco Ranieri; Elio Antonucci
Journal:  Ann Intensive Care       Date:  2020-09-16       Impact factor: 6.925

Review 6.  A Severe COVID-19 Case Complicated by Right Atrium Thrombus.

Authors:  Anastasia Anthi; Dimitrios Konstantonis; Maria Theodorakopoulou; Olympia Apostolopoulou; Irene Karampela; Georgia Konstantopoulou; Stavroula Patsilinakou; Apostolos Armaganidis; George Dimopoulos
Journal:  Am J Case Rep       Date:  2020-09-23

Review 7.  The overlooked chamber in coronavirus disease 2019.

Authors:  Yunshan Cao; Min Zhang; Yanqing Guo; Yan Zhang
Journal:  ESC Heart Fail       Date:  2020-09-16

8.  Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.

Authors:  Sara Tomerak; Safah Khan; Muna Almasri; Rawan Hussein; Ali Abdelati; Ahmed Aly; Mohammad A Salameh; Arwa Saed Aldien; Hiba Naveed; Mohamed B Elshazly; Dalia Zakaria
Journal:  Scand J Immunol       Date:  2021-09-27       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.